[CLSTR]
< Back to situations

[ORGANIZATION]

Dana-Farber Cancer Institute

Featured in 18 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [DE]

Biological drivers of colorectal cancer progression

2 clusters · 4 sources · last updated

Latest: MIT researchers link high-fat diets to colorectal cancer spread

Researchers have identified biological mechanisms that influence the progression and metastasis of colorectal cancer. Initial studies involving institutions such as Mass General Brigham Cancer Institute and the Broad In

[ACTIVE] [BUSINESS] [US] [CN] [ES]

Moderna and Merck melanoma vaccine clinical trials

12 clusters · 445 sources · last updated

Latest: Moderna shares hit 52-week high on cancer vaccine progress

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (also known as V940 or mRNA-4157), an experimental personalized mRNA cancer vaccine. The therapy is designed to target

[ACTIVE] [HEALTH] [DE] [US] [TR]

Advancements in personalized cancer immunotherapy

4 clusters · 17 sources · last updated

Latest: Pancreatic cancer research advances via immunotherapy and 3D modeling

The field of oncology is increasingly shifting toward personalized medicine, specifically through the use of targeted therapies and immunotherapy. Medical professionals emphasize that because ‘every cancer’s mechanism of

[ACTIVE] [HEALTH] [US] [BR]

FDA breast cancer treatment approvals and trial updates

5 clusters · 26 sources · last updated

Latest: Anvisa approves Etcamah for advanced breast cancer treatment in Brazil

The U.S. Food and Drug Administration (FDA) has issued approvals for new breast cancer treatments targeting advanced or metastatic cases. Initial approvals included AstraZeneca’s Etcamah (camizestrant), an oral selective

[ACTIVE] [HEALTH] [US] [GB]

EGFR T790M mutation and lung cancer risk

2 clusters · 20 sources · last updated

Latest: Medical studies link genetic mutations and diet to cancer risks

Researchers from the Dana-Farber Cancer Institute and the 23andMe Research Institute have identified a rare inherited genetic mutation, EGFR T790M, that significantly elevates lung cancer risk. A large-scale study publis

[QUIET] [HEALTH]

Long-term complications of cancer treatments

2 clusters · 3 sources · last updated

Latest: Long-term side effects of pelvic radiation and prostate cancer treatment

Medical research and clinical discussions are increasingly focused on the long-term complications and survivorship challenges associated with cancer treatments, particularly radiation therapy. In the context of brain me

[QUIET] [HEALTH] [US] [AT] [DE]

Newborn blood screening for childhood cancer risks

2 clusters · 5 sources · last updated

Latest: Genetic testing of newborn blood could reveal childhood cancer risks

Researchers have demonstrated that newborn heel-prick blood samples can be used to identify genetic predispositions for certain childhood cancers. A study involving nearly 2,000 archived dried blood samples from infants

[QUIET] [HEALTH] [US] [AU] [BR]

Rising colorectal cancer in younger adults

3 clusters · 11 sources · last updated

Latest: Global cancer trends show rise in early-onset cases

Medical research indicates a significant rise in colorectal cancer rates among adults under the age of 50. Globally, approximately 10% of diagnoses now occur in this younger demographic, with projections suggesting subst

[QUIET] [HEALTH] [US] [AT] [DE]

Biomedical research advancements in genetics and oncology

2 clusters · 11 sources · last updated

Latest: Medical researchers develop disease-predicting algorithm and cancer-fighting cells

Biomedical researchers in Europe and the United States have reported several advancements in genetics, disease prediction, and cancer therapy. Initial breakthroughs focused on epigenetics and targeted cancer treatments.

Also covered in